FindTrial
Sign In

safety and efficacy of oral triclofos in short duration examination in children

Safety and efficacy of oral triclofos in the ophthalmic evaluation of children with paediatric Glaucoma: A prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/08/015532
Enrollment
60
Registered
2018-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H59-H59- Intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified

Interventions

None listed

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Uncooperative and young children below the age of 12 years requiring EUA following surgery for paediatric glaucoma, no acute medical conditions in child, no history of cardio-respiratory disorder

Exclusion criteria

Exclusion criteria: children with cardiorespiratory distress, liver disease or an acute medical conditions

Design outcomes

Primary

MeasureTime frame
to assess the safety and efficacy of oral triclofos in dose of 80 mg/kg as sole anaesthetic agent for paediatric non-painful ophthalmic examination under anaesthesiaTimepoint: after 10 minute, 15 minutes, 20 minutes before surgery and 6 hour postoperatively—

Secondary

MeasureTime frame
mean time of onset of adequate sedation score, surgeon satisfaction score for completion of procedure, mean duration of drug, need of additional dose of pedicloryl, need of rescue general anaesthesia, adverse effects of pediclorylTimepoint: at 10 minutes, 15 minutes, 20 minutes before surgery and up to 6 hours in postoperative period—

Countries

India

Contacts

Public ContactSameer sethi

PGIMER, Chandigarh

sameersethi29@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026